Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) General Information

Description

Four approved abbreviated new drug applications based in Kansas City, Missouri.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kansas City, MO
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Kansas City, MO
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )‘s full profile, request access.

Request a free trial

Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )‘s full profile, request access.

Request a free trial

Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) FAQs

  • Where is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) headquartered?

    Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is headquartered in Kansas City, MO.

  • What industry is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) in?

    Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )’s primary industry is Buildings and Property.

  • Is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) a private or public company?

    Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is a Private company.

  • What is the current valuation of Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )?

    The current valuation of Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is .

  • What is Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )’s current revenue?

    The current revenue for Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) is .

  • Who are Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )’s investors?

    Nostrum Laboratories has invested in Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ).

  • When was Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) acquired?

    Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) was acquired on 29-Apr-2025.

  • Who acquired Nostrum Laboratories (Four Approved Abbreviated New Drug Applications )?

    Nostrum Laboratories (Four Approved Abbreviated New Drug Applications ) was acquired by Strides Pharma Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process